Aclerastide

N/A

Report date: 2024/04/02 20:00:40
NME

Base Information

Drug NameAclerastide
Drug Alias Nameaclerastidum阿勒司肽aclerastida阿克来肽DSC-127 +[6] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionStem cells stimulantsAngiotensin II receptor agonists
TargetsAngiotensin II receptor
Therapy Area/IndicationsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPuerto Rico +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDerma Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntegra Lifesciences CorporationUS Biotest Inc
Active IndicationsN/A
Inactive IndicationsDiabetic Foot

Other Information

ATC CodeN/A
Related LinksN/A